You are here: Home » Companies » Q&A
Business Standard

What is keeping Adar Poonawalla busy these days?

Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more

Topics
Serum Institute of India | Serum Institute | Vaccine

Sohini Das  |  New Delhi 



Adar Poonawalla
Adar Poonawalla (Photo: Kamlesh Pednekar)

ALSO READ

India working on indigenous kit to test monkeypox as cases on the rise

No need to panic over monkeypox, have taken steps to curb it: Kerala govt

India considering to develop monkeypox vaccine; SII CEO says no rush

Monkeypox can spread irrespective of sexual orientation, race: WHO

Week after India's first monkeypox case, global numbers rise further

  • Innovation has also been the key to the success of Adar Poonawala. He has taken Indian vaccines to the US and European markets. In an interview with Business Standard’s Sohini Das, Poonawalla tells about his plans, which include mass production of malaria vaccines, nasal flu and exploring a for monkeypox too. Let us listen in to the interview in this podcast.

    First Published: Thu, August 04 2022. 07:00 IST
    RECOMMENDED FOR YOU

    .